Mucosal immune responses in W/Wv and Sl/Sld mutant mice

Experimental Animals

Volumn 61, Issue 4, 2012, Pages 407-416

  Yoshino, Naoto ^a   Kanno, Hiroyuki ^a   Takahashi, Kiyomi ^a   Endo, Masahiro ^a   Sato, Shigehiro ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Gastrointestinal motility; Mast cell deficiency; Mucosal vaccine; Mutant mice

Indexed keywords

CHOLERA TOXIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CONGENIC STRAIN; EXPERIMENTAL MOUSE; FECES ANALYSIS; FEMALE; GASTROINTESTINAL MOTILITY DISORDER; HUMORAL IMMUNITY; IMMUNIZATION; INTERSTITIAL CELL OF CAJAL; INTESTINE MUCOSA; MOUSE; MOUSE MUTANT; MUCOSAL IMMUNITY; NONHUMAN;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; CHOLERA TOXIN; DISEASE MODELS, ANIMAL; FECES; FEMALE; GASTROINTESTINAL MOTILITY; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; MICE; MICE, MUTANT STRAINS; OVALBUMIN;

ANIMALIA; MURINAE; MUS;

EID: 84864515940     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.61.407     Document Type: Article

References (63)

1. A kira, S. 2011. Innate immunity and adjuvants. Philos. Trans. R. Soc. Lond. B Biol. Sci. 366: 2748-2755. [Medline] [CrossRef]
2. A zuma, T., Dojyo, M., Ito, S., Yamazaki, Y., Miyaji, H., Ito, Y., Suto, H., Kuriyama, M., Kato, T., and Kohli, Y. 1999. Bile reflux due to disturbed gastric movement is a cause of spontaneous gastric ulcer in W/Wv mice. Dig. Dis. Sci. 44: 1177-1183. [Medline] [CrossRef]
3. Baird, A.W. and Cuthbert, A.W. 1987. Neuronal involvement in type 1 hypersensitivity reactions in gut epithelia. Br. J. Pharmacol. 92: 647-655. [Medline]
4. Breuer, C., Oh, J., Molderings, G.J., Schemann, M., Kuch, B., Mayatepek, E., and Adam, R. 2010. Therapy-refractory gastrointestinal motility disorder in a child with c-kit mutations. World J. Gastroenterol. 16: 4363-4366. [Medline] [CrossRef]
5. Chappaz, S., Gärtner, C., Rodewald, H.R., and Finke, D. 2010. Kit ligand and Il7 differentially regulate Peyer's patch and lymph node development. J. Immunol. 185: 3514-3519. [Medline] [CrossRef]
6. Clements, J.D., Hartzog, N.M., and Lyon, F.L. 1988. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine 6: 269-277. [Medline] [CrossRef]
7. Cone, R.A. 2005. Mucus. pp. 49-72. In: Mucosal Immunology, 3rd Ed. (Mestecky, J., Lamm, M.E., McGhee, J.R., Bienenstock, J., Mayer, L., and Strober, W., eds.), Academic Press, San Diego.
8. Copeland, N.G., Gilbert, D.J., Cho, B.C., Donovan, P.J., Jenkins, N.A., Cosman, D., Anderson, D., Lyman, S.D., and Williams, D.E. 1990. Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell 63: 175-183. [Medline] [Cross-Ref]
9. Crowe, S.E., Sestini, P., and Perdue, M.H. 1990. Allergic reactions of rat jejunal mucosa. Ion transport responses to luminal antigen and inflammatory mediators. Gastroenterology 99: 74-82. [Medline]
10. Di Santo, J.P. and Rodewald, H.R. 1998. In vivo roles of receptor tyrosine kinases and cytokine receptors in early thymocyte development. Curr. Opin. Immunol. 10: 196-207. [Medline] [CrossRef]
11. Elson, C.O. and Ealding, W. 1984. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132: 2736-2741. [Medline]
12. Flanagan, J.G., Chan, D.C., and Leder, P. 1991. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 64: 1025-1035. [Medline] [CrossRef]
13. Fujihashi, K., Staats, H.F., Kozaki, S., and Pascual, D.W. 2007. Mucosal vaccine development for botulinum intoxication. Expert Rev. Vaccines 6: 35-45. [Medline] [CrossRef]
14. Galli, S.J. 1987. New approaches for the analysis of mast cell maturation, heterogeneity, and function. Fed. Proc. 46: 1906-1914. [Medline]
15. Gardner, E.M., Gonzalez, E.W., Nogusa, S., and Murasko, D.M. 2006. Age-related changes in the immune response to influenza vaccination in a racially diverse, healthy elderly population. Vaccine 24: 1609-1614. [Medline] [CrossRef]
16. Glück, R., Mischler, R., Durrer, P., Fürer, E., Lang, A.B., Herzog, C., and Cryz, S.J. Jr. 2000. Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant. J. Infect. Dis. 181: 1129-1132. [Medline] [CrossRef]
17. Glück, U., Gebbers, J.O., and Glück, R. 1999. Phase 1 evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers. J. Virol. 73: 7780-7786. [Medline]
18. Glueck, R. 2001. Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization. Vaccine 20: S42-S44. [Medline] [CrossRef]
19. Ha, T.Y., Reed, N.D., and Crowle, P.K. 1986. Immune response potential of mast cell-deficient W/Wv mice. Int. Arch. Allergy Appl. Immunol. 80: 85-94. [Medline] [CrossRef]
20. Hagiwara, Y., McGhee, J.R., Fujihashi, K., Kobayashi, R., Yoshino, N., Kataoka, K., Etani, Y., Kweon, M.N., Tamura, S., Kurata, T., Takeda, Y., Kiyono, H., and Fujihashi, K. 2003. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue. J. Immunol. 170: 1754-1762. [Medline]
21. Hanani, M. and Freund, H.R. 2000. Interstitial cells of Cajal-their role in pacing and signal transmission in the digestive system. Acta Physiol. Scand. 170: 177-190. [Medline] [CrossRef]
22. Huizinga, J.D., Thuneberg, L., Klüppel, M., Malysz, J., Mikkelsen, H.B., and Bernstein, A. 1995. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature 373: 347-349. [Medline] [CrossRef]
23. I maoka, K., Miller, C.J., Kubota, M., McChesney, M.B., Lohman, B., Yamamoto, M., Fujihashi, K., Someya, K., Honda, M., McGhee, J.R., and Kiyono, H. 1998. Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/ Th2 help for virus-specific immune responses in reproductive tissues. J. Immunol. 161: 5952-5958. [Medline]
24. Jackson, G.D., Lemaître-Coelho, I., Vaerman, J.P., Bazin, H., and Beckers, A. 1978. Rapid disappearance from serum of intravenously injected rat myeloma IgA and its secretion into bile. Eur. J. Immunol. 8: 123-126. [Medline] [CrossRef]
25. Jackson, R.J., Fujihashi, K., Xu-Amano, J., Kiyono, H., Elson, C.O., and McGhee, J.R. 1993. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect. Immun. 61: 4272-4279. [Medline]
26. Jacoby, W., Cammarata, P.V., Findlay, S., and Pincus, S.H. 1984. Anaphylaxis in mast cell-deficient mice. J. Invest. Dermatol. 83: 302-304. [Medline] [CrossRef]
27. Jawdat, D.M., Albert, E.J., Rowden, G., Haidl, I.D., and Marshall, J.S. 2004. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J. Immunol. 173: 5275-5282. [Medline]
28. Kitamura, Y. and Go, S. 1979. Decreased production of mast cells in S1/S1d anemic mice. Blood 53: 492-497. [Medline]
29. Kitamura, Y., Go, S., and Hatanaka, K. 1978. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 52: 447-452. [Medline]
30. Kitamura, Y., Yokoyama, M., Matsuda, H., and Shimada, M. 1980. Coincidental development of forestomach papilloma and prepyloric ulcer in nontreated mutant mice of W/Wv and SI/SId genotypes. Cancer Res. 40: 3392-3397. [Medline]
31. Kitamura, Y., Sonoda, T., Nakano, T., Hayashi, C., and Asai, H. 1985. Differentiation processes of connective tissue mast cells in living mice. Int. Arch. Allergy Appl. Immunol. 77: 144-150. [Medline] [CrossRef]
32. Klimpel, G.R., Chopra, A.K., Langley, K.E., Wypych, J., Annable, C.A., Kaiserlian, D., Ernst, P.B., and Peterson, J.W. 1995. A role for stem cell factor and c-kit in the murine intestinal tract secretory response to cholera toxin. J. Exp. Med. 182: 1931-1942. [Medline] [CrossRef]
33. Malysz, J., Thuneberg, L., Mikkelsen, H.B., and Huizinga, J.D. 1996. Action potential generation in the small intestine of W mutant mice that lack interstitial cells of Cajal. Am. J. Physiol. 271: G387-G399. [Medline]
34. Martín-Fontecha, A., Sebastiani, S., Höpken, U.E., Uguccioni, M., Lipp, M., Lanzavecchia, A., and Sallusto, F. 2003. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198: 615-621. [Medline] [CrossRef]
35. McLachlan, J.B., Hart, J.P., Pizzo, S.V., Shelburne, C.P., Staats, H.F., Gunn, M.D., and Abraham, S.N. 2003. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat. Immunol. 4: 1199-1205. [Medline] [CrossRef]
36. Moldoveanu, Z. and Fujihashi, K. 2005. Collection and processing of external secretions and tissues of mouse origin. pp. 1841-1852. In: Mucosal Immunology, 3rd Ed. (Mestecky, J., Lamm, M.E., McGhee, J.R., Bienenstock, J., Mayer, L., and Strober, W., eds.), Academic Press, San Diego.
37. Mutsch, M., Zhou, W., Rhodes, P., Bopp, M., Chen, R.T., Linder, T., Spyr, C., and Steffen, R. 2004. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N. Engl. J. Med. 350: 896-903. [Medline] [CrossRef]
38. Nakahara, M., Isozaki, K., Hirota, S., Vanderwinden, J.M., Takakura, R., Kinoshita, K., Miyagawa, J., Chen, H., Miyazaki, Y., Kiyohara, T., Shinomura, Y., and Matsuzawa, Y. 2002. Deficiency of KIT-positive cells in the colon of patients with diabetes mellitus. J. Gastroenterol. Hepatol. 17: 666-670. [Medline] [CrossRef]
39. Nakano, T., Kanakura, Y., Nakahata, T., Matsuda, H., and Kitamura, Y. 1987. Genetically mast cell-deficient W/Wv mice as a tool for studies of differentiation and function of mast cells. Fed. Proc. 46: 1920-1923. [Medline]
40. Nocka, K., Majumder, S., Chabot, B., Ray, P., Cervone, M., Bernstein, A., and Besmer, P. 1989. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice-evidence for an impaired c-kit kinase in mutant mice. Genes Dev. 3: 816-826. [Medline] [CrossRef]
41. Nocka, K., Tan, J.C., Chiu, E., Chu, T.Y., Ray, P., Traktman, P., and Besmer, P. 1990. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J. 9: 1805-1813. [Medline]
42. Okunuki, H., Teshima, R., Harikai, N., Sakai, S., Akiyama, H., Maitani, T., and Sawada, J. 2003. Oral sensitization of W/Wv mice with ovalbumin and possible involvement of the decrease in γδ-T cells. Biol. Pharm. Bull. 26: 1260-1265. [Medline] [CrossRef]
43. Perdue, M.H., Masson, S., Wershil, B.K., and Galli, S.J. 1991. Role of mast cells in ion transport abnormalities associated with intestinal anaphylaxis. Correction of the diminished secretory response in genetically mast cell-deficient W/ Wv mice by bone marrow transplantation. J. Clin. Invest. 87: 687-693. [Medline] [CrossRef]
44. S anders, K.M., Ordög, T., and Ward, S.M. 2002. Physiology and pathophysiology of the interstitial cells of Cajal: from bench to bedside. IV. Genetic and animal models of GI motility disorders caused by loss of interstitial cells of Cajal. Am. J. Physiol. Gastrointest. Liver Physiol. 282: G747-G756. [Medline]
45. S awamoto, T., Haruta, S., Kurosaki, Y., Higaki, K., and Kimura, T. 1997. Prediction of the plasma concentration profiles of orally administered drugs in rats on the basis of gastrointestinal transit kinetics and absorbability. J. Pharm. Pharmacol. 49: 450-457. [Medline] [CrossRef]
46. S hekels, L.L., Lyftogt, C.T., and Ho, S.B. 1996. Bile acidinduced alterations of mucin production in differentiated human colon cancer cell lines. Int. J. Biochem. Cell Biol. 28: 193-201. [Medline] [CrossRef]
47. S himada, M., Kitamura, Y., Yokoyama, M., Miyano, Y., Maeyama, K., Yamatodani, A., Takahashi, Y., and Tatsuta, M. 1980. Spontaneous stomach ulcer in genetically mastcell depleted W/Wv mice. Nature 283: 662-664. [Medline] [CrossRef]
48. Slütter, B., Hagenaars, N., and Jiskoot, W. 2008. Rational design of nasal vaccines. J. Drug Target. 16: 1-17. [Medline] [CrossRef]
49. Solari, R. and Kraehenbuhl, J.P. 1984. Biosynthesis of the IgA antibody receptor: a model for the transepithelial sorting of a membrane glycoprotein. Cell 36: 61-71. [Medline] [CrossRef]
50. Stead, R.H., Tomioka, M., Quinonez, G., Simon, G.T., Felten, S.Y., and Bienenstock, J. 1987. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc. Natl. Acad. Sci. U.S.A. 84: 2975-2979. [Medline] [CrossRef]
51. Tamura, S., Miyata, K., Matsuo, K., Asanuma, H., Takahashi, H., Nakajima, K., Suzuki, Y., Aizawa, C., and Kurata, T. 1996. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein. J. Immunol. 156: 3892-3900. [Medline]
52. Thuneberg, L. 1982. Interstitial cells of Cajal: intestinal pacemaker cells? Adv. Anat. Embryol. Cell Biol. 71: 1-130. [Medline] [CrossRef]
53. Underdown, B.J. and Schiff, J.M. 1986. Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu. Rev. Immunol. 4: 389-417. [Medline] [CrossRef]
54. Vanderwinden, J.M. and Rumessen, J.J. 1999. Interstitial cells of Cajal in human gut and gastrointestinal disease. Microsc. Res. Tech. 47: 344-360. [Medline] [CrossRef]
55. Ward, S.M., Burns, A.J., Torihashi, S., Harney, S.C., and Sanders, K.M. 1995. Impaired development of interstitial cells and intestinal electrical rhythmicity in steel mutants. Am. J. Physiol. 269: C1577-C1585. [Medline]
56. Wu, H.Y. and Russell, M.W. 1993. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 61: 314-322. [Medline]
57. Yamamoto, M., Briles, D.E., Yamamoto, S., Ohmura, M., Kiyono, H., and McGhee, J.R. 1998. A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A. J. Immunol. 161: 4115-4121. [Medline]
58. Yamamoto, S., Kiyono, H., Yamamoto, M., Imaoka, K., Fujihashi, K., van Ginkel, F.W., Noda, M., Takeda, Y., and Mc-Ghee, J.R. 1997. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. U.S.A. 94: 5267-5272. [Medline] [Cross-Ref]
59. Yamamoto, T., Watabe, K., Nakahara, M., Ogiyama, H., Kiyohara, T., Tsutsui, S., Tamura, S., Shinomura, Y., and Hayashi, N. 2008. Disturbed gastrointestinal motility and decreased interstitial cells of Cajal in diabetic db/db mice. J. Gastroenterol. Hepatol. 23: 660-667. [Medline] [CrossRef]
60. Yokoyama, M., Tatsuta, M., Baba, M., and Kitamura, Y. 1982. Bile reflux: a possible cause of stomach ulcer in nontreated mutant mice of W/Wv genotype. Gastroenterology 82: 857-863. [Medline]
61. Yoshino, N., Fujihashi, K., Hagiwara, Y., Kanno, H., Takahashi, K., Kobayashi, R., Inaba, N., Noda, M., and Sato, S. 2009. Co-administration of cholera toxin and apple polyphenol extract as a novel and safe mucosal adjuvant strategy. Vaccine 27: 4808-4817. [Medline] [CrossRef]
62. Yoshino, N., Lü, F.X., Fujihashi, K., Hagiwara, Y., Kataoka, K., Lu, D., Hirst, L., Honda, M., van Ginkel, F.W., Takeda, Y., Miller, C.J., Kiyono, H., and McGhee, J.R. 2004. A novel adjuvant for mucosal immunity to HIV-1 gp120 in nonhuman primates. J. Immunol. 173: 6850-6857. [Medline]
63. Zsebo, K.M., Williams, D.A., Geissler, E.N., Broudy, V.C., Martin, F.H., Atkins, H.L., Hsu, R.Y., Birkett, N.C., Okino, K.H., Murdock, D.C., Jacobsen, F.W., Langley, K.E., Smith, K.A., Takeish, T., Cattanach, B.M., Galli, S.J., and Suggs, S.V. 1990. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63: 213-224. [Medline] [CrossRef]